THE KIDNEY AND LIVER CONNECTION
This update is in response to the fact that new information is continually being uncovered regarding Plaquenil toxicity and testing for Plaquenil toxicity. The primary objective of this paper is to highlight the fact that the levels needed to achieve toxicity are related to the status of functioning of the liver and kidneys which work to clear the drug.
A SUMMARY OF THE MOST OFTEN USED MEDICATIONS
Health care providers should be cognizant of the potential side effects of the various medications prescribed to their patients by other providers. Those concerns must include self-prescribed over the counter agents. The pharmacist is the coordinator of the team regarding prescriptive medications. Included in the list of potential offenders should be some of the over-the-counter medications and nutraceuticals with some attention to the interaction of the various combinations in the management of the patients. For example, patients often do not consider the interactions of supplemental vitamin E or Gingko Biloba with often used anti-coagulants. Questioning of patients regarding all supplements that they may use is critical and must be recorded in the chart.
The latest guidelines on monitoring a patient on plaquenil plus a few cases.
A sample Word document (editable) that you can use in your own office. It details the latest required testing for plaquenil patients.
Writtenby Larry J Alexander OD FAAO
Posted in Letters/Brochures
A STORY THAT NEEDS TO BE TOLD
Recently new guidelines for the management of patients taking PLAQUENIL were released. Two of the authors of this article published in this area, being the first to point to the importance of assessing kidney and liver function in all patients scheduled to be placed on PLAQUENIL.
Wednesday, 20 February 2013
Written by Larry J Alexander OD FAAO, Kim Sneed, LPN, CNC, Dwayne Yeager BSRT, OD, FAAO
Posted in Philosophy/Editorials